| AASLD

Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy

Read more about Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy

Sanjiv Harpavat, Kieran Hawthorne, Kenneth D. R. Setchell, Monica Narvaez Rivas, Lisa Henn, Charlotte A. Beil, Saul J. Karpen, Vicky L. Ng, Estella M. Alonso, Jorge A. Bezerra, Stephen L. Guthery, Simon Horslen, Kathy M. Loomes, Patrick McKiernan, John C. Magee, Robert M. Merion, Jean P. Molleston, Philip Rosenthal, Richard J. Thompson, Kasper S. Wang, Ronald J. Sokol, Benjamin L. Shneider, for Childhood Liver Disease Research Network (ChiLDReN) – 20 September 2022

Interleukin‐33 facilitates liver regeneration through serotonin‐involved gut‐liver axis

Read more about Interleukin‐33 facilitates liver regeneration through serotonin‐involved gut‐liver axis

Yankai Wen, Christoph Emontzpohl, Long Xu, Constance L. Atkins, Jong‐Min Jeong, Yang Yang, Kangho Kim, Chuan Wu, Shizuo Akira, Cynthia Ju – 20 September 2022

Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes

Read more about Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes

Lung‐Yi Mak, Rex Wan‐Hin Hui, Chi‐Ho Lee, XianHua Mao, Ka‐Shing Cheung, Danny Ka‐Ho Wong, David Tak‐Wai Lui, James Fung, Man‐Fung Yuen, Wai‐Kay Seto – 20 September 2022

Fatty liver disease reverses the obesity paradox in chronic kidney disease stages 3–5: A follow‐up study of NHANES III

Read more about Fatty liver disease reverses the obesity paradox in chronic kidney disease stages 3–5: A follow‐up study of NHANES III

Jiaofeng Huang, Min Zhang, Yinlian Wu, Mingfang Wang, Yueyong Zhu, Su Lin – 19 September 2022 – High body mass index (BMI) has been associated with better survival in patients with end‐stage kidney disease. Individuals with fatty liver disease (FLD) have a higher risk of chronic kidney disease. It remains unclear whether the survival benefit of high BMI in patients with chronic kidney disease is present when there is concomitant FLD. This study used the data set from the Third American National Health and Nutrition Examination Survey and the corresponding survival data.

Diagnostic and prognostic performance of urinary neutrophil gelatinase‐associated lipocalin in patients with cirrhosis and acute kidney injury

Read more about Diagnostic and prognostic performance of urinary neutrophil gelatinase‐associated lipocalin in patients with cirrhosis and acute kidney injury

Carmine Gambino, Salvatore Piano, Matteo Stenico, Marta Tonon, Alessandra Brocca, Valeria Calvino, Simone Incicco, Nicola Zeni, Roberta Gagliardi, Chiara Cosma, Martina Zaninotto, Patrizia Burra, Umberto Cillo, Daniela Basso, Paolo Angeli – 19 September 2022

Practicality and potential restrictions of unresectable hepatocellular carcinoma prognostic index

Read more about Practicality and potential restrictions of unresectable hepatocellular carcinoma prognostic index

Coskun Ozer Demirtas, Gabrielle Ricco, Osman Cavit Ozdogan, Feyyaz Baltacioglu, Tunc Ones, Perran Fulden Yumuk, Ender Dulundu, Sinan Uzun, Pierro Colombatto, Filippo Oliveri, Maurizia Rosanna Brunetto, Feyza Gunduz – 19 September 2022

Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion

Read more about Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion

Damiano Patrono, Riccardo De Carlis, Alessandro Gambella, Francesca Farnesi, Alice Podestà, Andrea Lauterio, Francesco Tandoi, Luciano De Carlis, Renato Romagnoli – 18 September 2022 – End‐ischemic viability testing by normothermic machine perfusion (NMP) represents an effective strategy to recover liver grafts having initially been discarded for liver transplantation (LT). However, its results in the setting of significant (≥30%) macrovesicular steatosis (MaS) have not been specifically assessed.